Watching
ELF · e.l.f. Beauty, Inc.
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 19 October 2026; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A daily close below $91.44, the 14 August 2026 close and the low of the September recovery. A cut to fiscal 2027 sales guidance below $1.938 billion at the fiscal second-quarter report would also break the case.
Open pick Medium conviction, opened at $113.48. Kill line at open: $91.44 (daily close); graded by at the latest.
Catalyst (in 15 days)
How picks are graded →The thesis
e.l.f. Beauty raised its fiscal 2027 guidance, and rhode's European launch points to more sales growth. The fiscal second-quarter report on 4 November 2026 settles whether reported sales confirm it. The shares closed at $113.48 on 19 October 2026. That close is 17.1% below the 52-week high of $136.92 and 43.6% above the level of three months earlier.
The company's operating numbers have not changed since 5 August 2026. That day it reported fiscal first-quarter net sales of $479.4 million, up 36%, including $160 million from rhode. It raised fiscal 2027 sales guidance to $1.938–1.968 billion, or 18–20% growth, and adjusted earnings per share (EPS) guidance to $3.50–3.55. Coverage of the 5 August 2026 call reports management expecting second-quarter net sales growth in the mid-30s percent.
Analyst targets are the new information since the last note. On 19 October 2026 Jefferies raised its target to $132 and kept a Buy rating, and JPMorgan raised its target to $130 and kept an Overweight rating, according to Benzinga. That gives five October target increases above the current price and one below it: Morgan Stanley's $103 of 15 October 2026.
The narrative is maturing. The story is widely covered, and the only fresh facts since 5 August 2026 are target changes and product launches. The next operating data arrives on 4 November 2026. The year-ago comparison is the fiscal 2026 second quarter, reported on 5 November 2025: net sales of $343.9 million, up 14%, and a gross margin of 69%.
Bullish and bearish views on e.l.f. Beauty, Inc.
The bull case on e.l.f. Beauty, Inc. (ELF), in brief: Guidance rose on every line. The bear case: Tariff refunds lifted the margin beat.
Bull case
- Guidance rose on every line. On 5 August 2026, sales guidance rose to $1.938–1.968 billion from $1.835–1.865 billion. Adjusted EPS guidance rose to $3.50–3.55 from $3.27–3.32.
- The first quarter beat estimates by a wide margin. Benzinga reported adjusted EPS of $1.75 against a $0.72 estimate for the quarter ended 30 June 2026. Net sales of $479.4 million beat estimates near $429 million.
- Rhode's wider distribution arrived on schedule. On 30 September 2026 Sephora launched rhode in 19 European markets, online and in more than 500 stores, as Sephora's exclusive in Europe, according to Premium Beauty News and City AM. The November report is the first to include those sales.
- Analyst targets keep rising above the price. Benzinga lists Jefferies at $132 and JPMorgan at $130 on 19 October 2026, Citigroup at $130 on 14 October 2026, Baird at $120 on 7 October 2026 and Raymond James at $117 on 1 October 2026. All five sit above the $113.48 close.
- A new category line launched. On 5 October 2026 the company entered fragrance and body care with e.l.f. POP, led by the limited-edition Tromsø holiday collection. It has given no revenue figure for the line.
Bear case
- Tariff refunds lifted the margin beat. The company's 5 August 2026 release puts first-quarter gross margin at 83%, up about 1,400 basis points. About 1,050 of those points came from refunds of tariffs imposed under the International Emergency Economic Powers Act (IEEPA). That benefit looks like a one-off, so the second-quarter profit comparison is harder.
- One major broker's target sits below the price. Morgan Stanley kept an Equal-Weight rating on 15 October 2026 and raised its target to $103. That is under the $113.48 close of 19 October 2026.
- Reported growth includes acquired revenue. The $160 million of rhode sales sits inside the $479.4 million first-quarter total. The company does not disclose organic e.l.f. growth separately.
- The balance sheet carries acquisition debt. Total debt was $834.2 million against $344.2 million of cash at 30 June 2026, according to the first-quarter release.
- The shares have run ahead of the report. They rose 43.6% in the three months to 19 October 2026, and the 14-day relative strength index (RSI) reads 72.7. Readings above 70 conventionally mark an overbought stock.
Price setup
The shares closed at $113.48 on 19 October 2026, against $113.54 on 16 October 2026 and $108.13 on 14 October 2026. The 52-week high is $136.92, 17.1% above the latest close. The 14 August 2026 close of $91.44 marks the low of the September recovery and the level the case is graded against.
Crowding is visible in three places. The RSI of 72.7 shows stretched short-term buying after a 43.6% three-month gain. The earnings report falls on 4 November 2026, so the move up has come before the operating data. Several 2026 officer sales ran under 10b5-1 trading plans adopted on 3 March 2026, which makes their timing a weak signal of insider views. The analyst move is one-way: six target increases between 1 October 2026 and 19 October 2026, five of them above the price.
Catalysts, next 30 days
- 4 November 2026, after the close: fiscal second-quarter 2027 results and call. TipRanks lists the date as confirmed. This is the first quarter to include rhode's European Sephora sales. It tests the mid-30s growth expectation against the $343.9 million year-ago quarter, and shows whether the $1.938–1.968 billion sales range and $3.50–3.55 EPS range hold.
What would change the view
A cut to fiscal 2027 sales guidance below $1.938 billion on 4 November 2026 would break the case. So would second-quarter growth well short of the mid-30s, or rhode sales below the $160 million of the first quarter. An adjusted EPS range cut below $3.50 would show that the tariff-refund margin has reversed faster than guided. In price terms, a daily close below $91.44, the 14 August 2026 close, would erase the September recovery and end the thesis.
What it trades with
The shares trade with the consumer-discretionary group, which includes On Holding, Mattel, Ollie's Bargain Outlet and Wingstop. That group regained momentum in the week to 18 October 2026 after five weekly readings of slowing interest from 20 September to 11 October 2026. A renewed fade in the group would raise the bar the report has to clear.
The company's own risk is tariffs. About three-quarters of production was China-sourced as of the fiscal 2026 fourth-quarter report, so changes in US tariffs on Chinese goods feed directly into e.l.f.'s EPS guidance. Rhode's results tie the shares to Sephora's European store traffic, and e.l.f. Hair ties them to Target's US distribution decisions.
Notes
- Fiscal year ends 31 March: fiscal 2027 Q2 covers the quarter ending September 2026, and fiscal 2027 guidance covers the year to 31 March 2027.
- Headline growth blends acquired rhode revenue with organic e.l.f. sales; the company does not disclose the organic figure separately.
- e.l.f. Hair sells through Target as its exclusive US retail partner, so one retailer's distribution decisions gate that line.
- About three-quarters of production was China-sourced as disclosed at the fiscal 2026 Q4 report; tariff changes feed directly into the EPS guidance.
- Fiscal Q1 2027 gross margin included about 1,050 basis points of IEEPA tariff refunds, which complicates year-over-year margin comparisons.
- Several 2026 officer sales run under 10b5-1 plans adopted 3 March 2026, so their timing says little about price views at execution.
Related · shared themes
AOUT
American Outdoor Brands, Inc.
American Outdoor Brands' 53.0% gross margin, raised profit guidance and $10 million buyback lifted the shares to an $18.06 high on 16 October 2026; the early-December fiscal second-quarter report shows whether that margin holds.
ARHS
Arhaus, Inc.
Arhaus's recovery case rests on Q2's 12.5% furniture-order growth turning into faster delivered sales. The Q3 report, expected 5 November 2026, settles it: comparable delivered-sales growth needs to beat Q2's 4.0%, near the top of the company's -1% to +5% guidance.
CRSR
Corsair Gaming, Inc.
Corsair Gaming's margin recovery has lifted earnings estimates and analyst targets, with the shares closing at $13.08 on 19 October 2026; the 5 November 2026 third-quarter report shows whether profit holds without the tariff refund and against rising memory costs.
EL
The Estee Lauder Companies Inc. Class A
Estée Lauder's turnaround shows in its margins, with fiscal 2026 adjusted operating margin up 3.2 points to 11.2% and the 2027 outlook raised; the first-quarter report on 2 November 2026 shows whether sales growth confirms it.
See also · stocks to watch